As a globally recognized GLP-1 receptor agonist (GLP-1 RA), Semaglutide 10mg represents a paradigm shift in metabolic disease management, chronic weight management therapeutics, and advanced peptide delivery systems. As a leading manufacturer and direct exporter of pharmaceutical-grade active pharmaceutical ingredients (APIs), Gentolex delivers enterprise-level peptide synthesis engineered to meet the stringent purity, bioactivity, and physical stability criteria demanded by global pharmaceutical developers, clinical trial sponsors, and generic drug formulators.
| Parameter / Test Item | Acceptance Criteria | Analytical Methodology |
|---|---|---|
| Chemical Name | Semaglutide (CAS RN: 910463-68-2) | IUPAC Standard Nomenclature |
| Molecular Formula & Weight | C187H291N45O59 | 4113.58 g/mol | High-Resolution Mass Spectrometry (HRMS) |
| Physical Appearance | White to off-white, dense lyophilized powder cake | Visual Inspection |
| Purity (HPLC) | ≥ 99.5% (Individual peak area integration) | RP-HPLC (C18 Column, Gradient Elution) |
| Bacterial Endotoxins | < 0.05 EU/mg | LAL Kinetic Chromogenic Method (USP <85>) |
| Counter-Ion Content | Acetate content ≤ 12.0% | TFA content ≤ 0.1% | Ion Chromatography (IC) |
| Residual Solvents | Meets ICH Q3C Guidelines (Acetonitrile <410ppm, DMF <880ppm) | Headspace GC-MS |
| Water Content (Karl Fischer) | ≤ 5.0% w/w | Coulometric Karl Fischer Titration |
Semaglutide is a modified 31-amino acid human GLP-1 analogue featuring two key structural modifications that deliver its extended plasma half-life of approximately 165 hours. The primary sequence contains an Aib (2-aminatedoisobutyric acid) substitution at position 8 to prevent cleavage by Dipeptidyl Peptidase-4 (DPP-4). Furthermore, a hydrophobic C18 fatty diacid side-chain is conjugated to the Lysine residue at position 26 via a bis-aminoethoxyethoxyacetyl (AEEA) link.
Utilizing high-yield Fmoc/tBu chemistry on automated industrial-scale peptide synthesizers. Our process minimizes racemization of delicate amino acid residues while maximizing chain assembly efficiency.
Precision attachment of the Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH side-chain fragment ensures complete chemical uniformity and eliminates structural isomers during downstream purification.
Multi-stage reverse-phase preparative chromatography isolates the primary peak with >99.5% optical purity. Custom cycle freeze-drying yields an instantly soluble, high-density lyophilized cake.
Navigating the global procurement landscape for metabolic active ingredients requires balancing regulatory compliance, production scale, and unit economics. China has established itself as the global epicenter for peptide raw materials, protected amino acid precursors, and bulk API synthesis. Gentolex leverages this vertically integrated infrastructure to provide global buyers with unmatched strategic security.
By producing protected amino acids (such as Fmoc-L-Lys derivatives) in-house, Gentolex eliminates supply bottlenecks and ensures complete traceability from basic building blocks to finished 10mg vials.
Our state-of-the-art manufacturing campus operates under international cGMP guidelines, featuring cleanroom suites (ISO Class 5 to 8) capable of multi-kilogram batch output.
Direct manufacturer pricing enables pharmaceutical partners to optimize R&D budgets and reduce commercial Finished Dosage Form (FDF) production costs by up to 40% compared to Western CDMOs.
From API synthesis to FDF licensing out, technical consultation, laboratory setup, and global logistics, Gentolex acts as a single-point strategic partner.
Demand for Semaglutide 10mg extends beyond conventional subcutaneous injection formulations. Procurement teams across biotech firms, compounding pharmacies, academic research institutions, and contract manufacturers require tailored solutions aligned with regional regulatory framework requirements.
Standard high-purity batching for multi-dose pen cartridges and single-dose auto-injector pre-filled syringes (PFS). Requires strict control of sub-visible particles and monomer content (>99.0%).
Co-formulation research combining bulk Semaglutide API with absorption enhancers such as Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC) to facilitate gastric mucosa permeation.
Established representative offices and regional staging facilities in key emerging markets—including Mexico and South Africa—simplify customs clearance and expedite local delivery.
Cross-border procurement of high-value peptides requires absolute compliance with regional pharmaceutical laws and stringent temperature controls. Gentolex has built an international compliance matrix ensuring seamless clearance and product stability from factory gate to client facility.
Every shipment is backed by comprehensive analytical documentation including HPLC-MS spectra, COA, MSDS, Stability Data (Accelerated & Long-term), residual solvent analysis, and TSE/BSE-free certification.
Semaglutide 10mg lyophilized vials are dispatched in validated thermal packaging with VIP insulation panels and digital IoT temperature loggers providing real-time thermal tracking during express air transit.
With direct operational presence in LATAM (Mexico) and Africa (South Africa), our regulatory specialists assist local formulators with import permits, sanitary registrations, and COFEPRIS / SAHPRA compliance filings.
The global market for metabolic peptides is undergoing exponential expansion. Driven by expanding clinical indications in cardiovascular risk reduction, non-alcoholic steatohepatitis (NASH/MASH), and neurodegenerative disorders, the demand for GLP-1 analogues like Semaglutide is set to surge over the next decade.
Transition from mono-GLP-1 therapies toward GLP-1/GIP (Tirzepatide) and GLP-1/GIP/Glucagon (Retatrutide) multi-receptor agonists requiring multi-step complex synthesis platforms.
Adoption of eco-friendly coupling reagents and recyclable solvent recovery systems reduces hazardous waste generation by 60% without compromising batch yield or purity.
Development of long-acting depot hydrogels, microneedle transdermal patches, and oral lipid nanoparticle (LNP) carriers expanding beyond traditional subcutaneous injections.
Preparing global generic drug manufacturers for patent cliff transitions with DMF readiness, process validation, and bioequivalence batch support.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard allows us to offer flexible, scalable and cost-effective solutions for clients globally.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Tailored peptide sequences, specific counter-ion exchanges (acetate, HCl, trifluoroacetate), and modified side chains designed for proprietary biotech research.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence TKPRPGP derived from endogenous neuro-peptides...
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and researchers...
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair...
With continuous developments in neuroscience and peptide technology, Semax has attracted wide scientific investigation as a neuroactive ACTH fragment derivative...
SS-31 API, also known as Elamipretide, MTP-131, and Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in cellular membranes...
![OEM Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH Company, Products](https://site.cdnfile.io/www.gentolexchemicals.com/3f742f7e381d499e73c3be66ef1d3e97300_300.webp)
![Buy Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH](https://site.cdnfile.io/www.gentolexchemicals.com/d499c45499c42e867ffd3c50b9686f2c300_300.webp)
